729 related articles for article (PubMed ID: 26642243)
21. Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis.
Pękalski J; Zuk PJ; Kochańczyk M; Junkin M; Kellogg R; Tay S; Lipniacki T
PLoS One; 2013; 8(11):e78887. PubMed ID: 24324544
[TBL] [Abstract][Full Text] [Related]
22. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
23. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
[TBL] [Abstract][Full Text] [Related]
24. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.
Pranski EL; Van Sanford CD; Dalal NV; Orr AL; Karmali D; Cooper DS; Costa N; Heilman CJ; Gearing M; Lah JJ; Levey AI; Betarbet RS
Neurosci Lett; 2012 Jun; 520(1):104-9. PubMed ID: 22634524
[TBL] [Abstract][Full Text] [Related]
25. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
26. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
27. TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6.
Franco-Jarava C; Wang H; Martin-Nalda A; Alvarez SD; García-Prat M; Bodet D; García-Patos V; Plaja A; Rudilla F; Rodriguez-Sureda V; García-Latorre L; Aksentijevich I; Colobran R; Soler-Palacín P
Clin Immunol; 2018 Jun; 191():44-51. PubMed ID: 29572183
[TBL] [Abstract][Full Text] [Related]
28. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
Funakoshi M; Tago K; Sonoda Y; Tominaga S; Kasahara T
Biochem Biophys Res Commun; 2001 Apr; 283(1):248-54. PubMed ID: 11322796
[TBL] [Abstract][Full Text] [Related]
29. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
30. XEDAR activates the non-canonical NF-κB pathway.
Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R
Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321
[TBL] [Abstract][Full Text] [Related]
31. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
[TBL] [Abstract][Full Text] [Related]
32. A20-mediated negative regulation of canonical NF-κB signaling pathway.
Pujari R; Hunte R; Khan WN; Shembade N
Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
[TBL] [Abstract][Full Text] [Related]
33. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
[TBL] [Abstract][Full Text] [Related]
34. The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.
Peinado C; Kang X; Hardamon C; Arora S; Mah S; Zhang H; Ngolab J; Bui JD
Immunology; 2013 Jun; 139(2):265-74. PubMed ID: 23350962
[TBL] [Abstract][Full Text] [Related]
35. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain.
Bohgaki M; Tsukiyama T; Nakajima A; Maruyama S; Watanabe M; Koike T; Hatakeyama S
Biochim Biophys Acta; 2008 May; 1783(5):826-37. PubMed ID: 18029035
[TBL] [Abstract][Full Text] [Related]
36. [Clinical phenotype and immunological features of a patient with A20 haploinsufficiency].
Huang YY; He TY; Xia Y; Luo Y; Weng RH; Luo SL; Yang J; Zhao XD
Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):218-222. PubMed ID: 32135594
[No Abstract] [Full Text] [Related]
37. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
38. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
39. RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway.
Murakawa Y; Hinz M; Mothes J; Schuetz A; Uhl M; Wyler E; Yasuda T; Mastrobuoni G; Friedel CC; Dölken L; Kempa S; Schmidt-Supprian M; Blüthgen N; Backofen R; Heinemann U; Wolf J; Scheidereit C; Landthaler M
Nat Commun; 2015 Jul; 6():7367. PubMed ID: 26170170
[TBL] [Abstract][Full Text] [Related]
40. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease.
Aeschlimann FA; Batu ED; Canna SW; Go E; Gül A; Hoffmann P; Leavis HL; Ozen S; Schwartz DM; Stone DL; van Royen-Kerkof A; Kastner DL; Aksentijevich I; Laxer RM
Ann Rheum Dis; 2018 May; 77(5):728-735. PubMed ID: 29317407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
